Advertisement

Reactions Weekly

, Volume 1761, Issue 1, pp 144–144 | Cite as

Docetaxel/pertuzumab/trastuzumab

Allergy: case report
Case report
  • 6 Downloads

Reference

  1. Suleman K, et al. Retrospective review of Her2 positive metastatic breast cancer patients who received Pertuzumab and Herceptin as a first line therapy at KFSH&RC (single institute experience) from 2013 to 2016. Breast 44 (Suppl. 1): S64 abstr. P144, Apr 2018. Available from: URL: http://doi.org/10.1016/S0960-9776%2819%2930245-0 [abstract] - Saudi Arabia

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations